We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thrombosis: Balancing act.
- Authors
Willyard, Cassandra
- Abstract
The article discusses research on haemophilia treatment therapy that involves inhibition of anticoagulants such as tissue factor pathway inhibitor (TFPI) and antithrombin. The efforts by pharmaceutical companies like Novo Nordisk, Baxter International and Alnylam Pharmaceuticals to find effective ways to treat hemophilia are discussed. Compounds such as concizumab and ALN-AT3 which could be used for treatment are mentioned.
- Subjects
HEMOPHILIA treatment; BLOOD coagulation disorders; ANTICOAGULANTS; NOVO Nordisk A/S; ALNYLAM Pharmaceuticals Inc.; BAXTER International Inc.; ANTITHROMBINS; HEMOPHILIA; GENETICS; BLOOD disease treatment
- Publication
Nature, 2014, Vol 515, Issue s7528, pS168
- ISSN
0028-0836
- Publication type
Article
- DOI
10.1038/515S168a